The tobacco giant is concerned over the FDA’s nicotine messaging and what they view as misconceptions about the substance.
Richmond, Va.-based Altria Group asked the Food and Drug Administration and its Center for Tobacco Products to clarify the agency’s position on nicotine.
CSP Daily News reports that Altria wants the Center for Tobacco Products to “correct the deeply entrenched public misperceptions regarding the health risks of nicotine.”
This favor was asked by Paige Magness, Altria’s senior vice president of regulatory affairs, via a letter directly addressed to CTP director Mitch Zeller.
“Left unaddressed, these widespread nicotine misperceptions could discourage adult smokers from switching to non-combustible tobacco products that may present lower health risk as compared to combustible cigarettes,” Magness said in a letter.
Michael McGrady – VapingPost – March 18, 2021.